Article
Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations.
Journal of clinical microbiology - 1 Jan 2003
Sayer D C, Land S, Gizzarelli L, French M, Hales G, Emery S, Christiansen F T, Dax E M
Abstract excerpt
Genotypic antiretroviral testing is now widely used for the management of patients who are undergoing antiretroviral therapy for human immunodeficiency virus infection. The assays are complex, and there is considerable potential for variation between laboratories. Informative and ongoing quality assessment programs (QAPs) which address all aspects of testing are required. The panel distribution of clinical...
Topics
- Anti-HIV Agents
- Antiretroviral Therapy, Highly Active
- Drug Resistance, Viral
- Environmental Monitoring
- Genotype
- HIV Infections
- HIV Reverse Transcriptase
- HIV-1
- Humans
- Mutation
- Sequence Analysis, DNA